KRMD
KORU Medical Systems, Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$4.06-1.22%
Price as of Jul 20, 2026
KRMD financials
KORU Medical Systems, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $41.1M | $33.6M | $28.5M | $27.9M |
| Cost of revenue | $15.5M | $12.3M | $11.8M | $12.5M |
| Gross profit | $25.6M | $21.3M | $16.7M | $15.4M |
| Operating expenses | $28.6M | $27.8M | $27.0M | $26.1M |
| Operating income | -$3.0M | -$6.4M | -$10.3M | -$10.8M |
| Net income | -$2.6M | -$6.1M | -$13.7M | -$8.7M |
| EBITDA | -$1.8M | -$5.3M | -$8.9M | -$10.1M |
| Basic EPS | $-0.06 | $-0.13 | $-0.30 | $-0.19 |
| Diluted EPS | $-0.06 | $-0.13 | $-0.30 | $-0.19 |
| Balance sheet | ||||
| Cash & equivalents | $8.9M | $9.6M | $11.5M | $17.4M |
| Total assets | $28.2M | $27.2M | $28.5M | $42.3M |
| Total liabilities | $11.2M | $10.4M | $8.1M | $11.0M |
| Stockholders’ equity | $17.0M | $16.8M | $20.4M | $31.3M |
| Total debt | $3.5M | $4.0M | $4.4M | $4.9M |
| Net debt | -$5.4M | -$5.6M | -$7.0M | -$12.5M |
| Cash flow | ||||
| Operating cash flow | $462.4K | -$319.7K | -$4.9M | -$5.4M |
| Capital expenditure | -$932.5K | -$1.3M | -$814.6K | -$2.8M |
| Free cash flow | -$470.1K | -$1.6M | -$5.7M | -$8.2M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | -$97.4K | $0.00 | $0.00 |